Question Bank › The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the

Calls Tested
500
Answered YES
5
Hit Rate
1%
rare by design

Catalyst Pharmaceuticals, Inc. (CPRX) — this company's answers

NO on the Q2 2021 call 2021-08-10 C+
The model's full reasoning — Q2 2021 call → NOWe need answer YES or NO based only transcript. Need determine if management describes growing share of revenue arrives without new selling event through reorders/refills/renewals/repeat purchases etc, and that this self-arriving share has recently and visibly grown as proportion, grounded in observed current behavior, treating as changing quality of revenue. Let's parse transcript. Company sells Firdapse for LEMS. Revenue from patients on therapy. They discuss new patient enrollments, discontinuations, persistency. Jeff: "Strong net revenue in Q2 was driven primarily by steady new patient enrollments, continued favorable reimbursement dynamics, and stable discontinuation rates." "Q2 new patient enrollments were 111% higher for the quarter versus same quarter last year. In first half 2021, new naïve to 3,4-DAP patient enrollments were 42% higher than first half 2020. Our strong patient persistency resulted in continued low 90-day discontinuation rates of less than 15%. Through first half 2021, discontinuations were 25% lower than first half 2020." This indicates revenue from existing patients continuing (persistency) and discontinuations lower. But is that "self-arriving revenue" growing share? They mention new patient enrollments driving revenue. They don't explicitly say share of revenue from reorders/refills has grown. They talk about patient persistency and discontinuations lower. But is that a "recently and visibly grown as proportion"? They say discontinuations 25% lower than first half 2020, so existing patients staying longer, thus repeat revenue from installed base may be larger share. However, they also emphasize new patient enrollments higher. Need see if management describes that a growing share of revenue now arrives without new selling event. They mention "stable discontinuation rates" and "strong patient persistency" - that's repeat behavior. But do they frame as proportion of business recently grown? They say "Through first half of 2021, discontinuations were 25% lower than first half of 2020." That means more patients continue, so repeat revenue from existing patients is higher relative to? But new patient enrollments also higher. They don't explicitly say "share of revenue from existing patients has grown." They mention "steady new patient enrollments" as driver.

← Back to the full CPRX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a GROWING SHARE OF THE COMPANY'S REVENUE NOW ARRIVES WITHOUT A NEW SELLING EVENT — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has RECENTLY AND VISIBLY GROWN as a proportion of the business, with management grounding the shift in observed current behavior and treating it as changing the company's quality of revenue? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent recent shift with both halves present: (1) SELF-ARRIVING REVENUE, OBSERVED NOW: management points to real, current repeat-mechanism revenue — reorder rates, renewal behavior, consumable or aftermarket attach, usage growth from installed product, or customers reordering on their own schedule — described with concrete grounding in the recent period, not asserted through generic 'recurring revenue' or 'loyal customers' language; and (2) THE PROPORTION HAS RECENTLY MOVED: management conveys that this self-arriving component is a visibly LARGER share of the business than it recently was — through an installed base that has recently scaled, a consumable or service stream now compounding on top of equipment already placed, or repeat behavior recently strengthening — so the company's revenue is becoming progressively less dependent on winning each sale, with the mix still early in its shift. Answer NO if the business has always been overwhelmingly recurring or contractual with nothing recently shifted. NO if repeat language is boilerplate with no observed behavior or recent change. NO if the repeat revenue is forced by contract lock-in with no customer choice described. NO if the shift is only planned or hoped for. NO if the pattern rests on one anecdote, or appears only in an analyst's question management does not affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IRBT iRobot Corporation Q3 2021 2021-10-28 D
TOUR Tuniu Corporation Q4 2017 2018-03-14 D

How the model reasoned

DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.

More from the question bank

Named catch-up gapWorking for customers it could not have servPaid to expand: the company's growth spendinVolume records through a still-fixed gateRecently unlocked doorSelling something whose payoff to the buyer All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.